Last reviewed · How we verify

NCT05284305

Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.

Status unknown Last updated 27 January 2023
What this trial tests

trial testing Pregnancy in Desmoid in 400 participants. Status unknown.

Timeline
1 March 2022
Primary endpoint
30 April 2023
15 May 2023

Quick facts

Lead sponsorFondazione IRCCS Istituto Nazionale dei Tumori, Milano
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment400
Start date1 March 2022
Primary completion30 April 2023
Estimated completion15 May 2023
Sites7 locations across France, Canada, United States, Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano — full company profile →

Who can join

18 and older, female only, with Desmoid or Desmoid; Abdominal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Desmoid tumors (DT) are rare disease of intermediate malignancy with variable and often unpredictable clinical course. There is a growing interest in defining potential risk of recurrence or progression during or after pregnancy and in identifying potential obstetrical risks and infertility rate of desmoid patients. Aim of the study: * to define the impact of pregnancy on diagnosis, progression and recurrence of DT; * to define the risks related to DT of obstetrical risks and decisions to interrupt or avoid pregnancy after the diagnosis of DT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pregnancy

Trials testing the same drug.

Other recruiting trials for Desmoid

Currently open trials in the same condition.

Other Fondazione IRCCS Istituto Nazionale dei Tumori, Milano trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05284305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing